Back

GLP-1 RA as first-line therapy to improve outcomes?

1 September 2024 (11:15 - 11:30)
Organised by: Logo
Congress Presentation Part of: The impact of obesity management on cardiovascular outcomes Obesity ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Professor Paolo Sbraccia

Tor Vergata University Hospital Polyclinic, Rome (Italy)

3 More presentations in this session

Presentation thumbnail
Metabolic bariatric surgery as first-line therapy to improve outcomes
Professor G. Fruhbeck (Pamplona, ES)
Slides Video
Presentation thumbnail
Lifestyle intervention in HFpEF with obesity to improve outcomes
Professor E. Van Craenenbroeck (Edegem, BE)
Slides Video
Presentation thumbnail
HFpEF patients with obesity and atrial fibrillation: role of exercise and ablation
Doctor S. Wernhart (Munich, DE)
Slides Video

Access the full session

Session thumbnail
The impact of obesity management on cardiovascular outcomes
Video

The Event

Event poster

ESC Congress 2024

1 September 2024 11:15 CET
You may be interested in
thumbnail
Congress Presentation
Why cardiologists should be interested in obesity and its treatment
thumbnail
Congress Presentation
GIP and GLP-1 agonists for obesity
thumbnail
Congress Presentation
Current approaches to the prevention and management of obesity

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources